Home NDC 63629-6764 azithromycin
Product NDC 63629-6764
11-digit product format 636296764
Labeler code 63629
Product ID 63629-6764_166f9a84-23a7-4a59-bff3-794d824d4611
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name azithromycin
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Bryant Ranch Prepack
Application NDA050784
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2002-05-24
Marketing end 0000-00-00
Substance AZITHROMYCIN DIHYDRATE
Active strength 500 mg/1
Pharmacologic classes Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 39 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63629-6764-1 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63629-6764-2 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63629-6764-1 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63629-6764-2 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63629-6764-1 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 63629-6764-2 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63629-6764-1 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 63629-6764-2 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63629-6764-1 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 63629-6764-2 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63629-6764-1 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 63629-6764-2 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63629-6764-1 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 63629-6764-2 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63629-6764-1 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 63629-6764-2 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63629-6764-1 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 63629-6764-2 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63629-6764-1 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 63629-6764-2 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63629-6764-1 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 63629-6764-2 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63629-6764-1 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 63629-6764-2 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 63629-6764-1 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 63629-6764-2 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050784-001 ZITHROMAX AZITHROMYCIN EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N050784-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N050784-001 ZITHROMAX EQ 500MG BASE TABLET / ORAL AB RLD 2002-05-24 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
FDA-Initiated Inactive NDC Indexing# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Zithromax AZITHROMYCIN DIHYDRATE Pfizer Laboratories Div Pfizer Inc db52b91e-79f7-4cc1-9564-f2eee8e31c45 2026-07-24 Warnings, Adverse reactions Exact identifier application applno (NDA): 050784 application number: NDA050784
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 63629-6764-1 63629676401 2 TABLET, FILM COATED in 1 BOTTLE (63629-6764-1) 2015-09-15 0000-00-00 No No Current 63629-6764-2 63629676402 14 TABLET, FILM COATED in 1 BOTTLE (63629-6764-2) 2015-09-15 0000-00-00 No No Current